Research programme: antibody - AskGene Pharma
Alternative Names: Antibody - AskGene PharmaLatest Information Update: 28 Nov 2025
At a glance
- Originator AskGene Pharma
- Class Antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Nov 2025 No recent reports of development identified for preclinical development in Unspecified in China (Parenteral)
- 21 Oct 2021 AskGene Pharma files an IND application with the regulatory body in China for Unspecified indication
- 21 Oct 2021 AskGene Pharma plans a clinical trial for Unspecified indication in China (Parenteral)